Gryglewski R J, Nicolaou K C
Experientia. 1978 Oct 15;34(10):1336-8. doi: 10.1007/BF01981457.
6,9-Thiaprostacyclin was used as a representative of prostacyclin analogues with the aim to design the most convenient procedure for evaluation of vasodilator, anti-platelet and other biological properties within this new group of potential anti-thrombotic agents.
6,9-硫前列环素被用作前列环素类似物的代表,目的是设计出最简便的程序,用于评估这组新型潜在抗血栓形成药物的血管舒张、抗血小板及其他生物学特性。